(Bloomberg) -- Canadian stocks fell, led by Biovail
Corp. after regulators rejected the drugmaker's application for
approval of an antidepressant.
The S&P/TSX Composite Index dropped for the first time in four
days, falling 31.50, or 0.2 percent, to 14,594.26 in Toronto at
10:02 a.m. in Toronto.
Read more at Bloomberg Stocks News
Corp. after regulators rejected the drugmaker's application for
approval of an antidepressant.
The S&P/TSX Composite Index dropped for the first time in four
days, falling 31.50, or 0.2 percent, to 14,594.26 in Toronto at
10:02 a.m. in Toronto.
Read more at Bloomberg Stocks News
No comments:
Post a Comment